No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs530603952 |
chr14:104352216-104352217 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs10634675 |
chr14:104352227-104352228 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs368581057 |
chr14:104352228-104352229 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs10678669 |
chr14:104352229-104352230 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs71305063 |
chr14:104352230-104352231 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs34533310 |
chr14:104352233-104352234 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs375186530 |
chr14:104352244-104352245 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs369351170 |
chr14:104352263-104352264 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs117674348 |
chr14:104352275-104352276 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs529512032 |
chr14:104352304-104352305 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs372927478 |
chr14:104352326-104352327 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs561900365 |
chr14:104352354-104352355 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs566361121 |
chr14:104352355-104352356 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs377219717 |
chr14:104352364-104352365 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs8009053 |
chr14:104352371-104352372 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs189067572 |
chr14:104352436-104352437 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs11622194 |
chr14:104352450-104352451 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs537310721 |
chr14:104352465-104352466 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs8009235 |
chr14:104352484-104352485 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs536026790 |
chr14:104352635-104352636 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs534785463 |
chr14:104352637-104352638 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs552937586 |
chr14:104352677-104352678 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs573067186 |
chr14:104352683-104352684 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs147998510 |
chr14:104352696-104352697 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs564179702 |
chr14:104352697-104352698 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs564862523 |
chr14:104352716-104352717 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs575333759 |
chr14:104352725-104352726 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs532548758 |
chr14:104352736-104352737 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs544276313 |
chr14:104352752-104352753 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs560973368 |
chr14:104352753-104352754 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs143442457 |
chr14:104352754-104352755 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs549534069 |
chr14:104352783-104352784 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs562663852 |
chr14:104352797-104352798 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs147128154 |
chr14:104352798-104352799 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs138550284 |
chr14:104352846-104352847 |
Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs144141454 |
chr14:104352923-104352924 |
Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs186312764 |
chr14:104352926-104352927 |
Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs911338 |
chr14:104352928-104352929 |
Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs550603983 |
chr14:104352935-104352936 |
Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs73350581 |
chr14:104352999-104353000 |
Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs536373630 |
chr14:104353028-104353029 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs147947530 |
chr14:104353039-104353040 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs368410805 |
chr14:104353059-104353060 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs377387012 |
chr14:104353062-104353063 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs572966727 |
chr14:104353136-104353137 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs538896424 |
chr14:104353140-104353141 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs150692867 |
chr14:104353141-104353142 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs575270457 |
chr14:104353149-104353150 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs139913926 |
chr14:104353154-104353155 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs371289712 |
chr14:104353237-104353238 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|